dacarbazine and Venous Thromboembolism

dacarbazine has been researched along with Venous Thromboembolism in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Åkesson, L; Enblad, G; Fohlin, H; Glimelius, B; Glimelius, I; Goldkuhl, C; Lagerlöf, I; Molin, D; Palma, M1
Achawal, S; Dixit, S; Hingorani, M; Scott, I1
Davis, ME; Stoiber, AM1

Reviews

2 review(s) available for dacarbazine and Venous Thromboembolism

ArticleYear
The sequential use of carmustine wafers (Gliadel®) and post-operative radiotherapy with concomitant temozolomide followed by adjuvant temozolomide: a clinical review.
    British journal of neurosurgery, 2011, Volume: 25, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Chemotherapy, Adjuvant; Dacarbazine; Decanoic Acids; Drug Implants; Glioblastoma; Hematologic Diseases; Humans; Middle Aged; Multicenter Studies as Topic; Polyesters; Postoperative Care; Postoperative Complications; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Temozolomide; Venous Thromboembolism; Young Adult

2011
Glioblastoma multiforme: enhancing survival and quality of life.
    Clinical journal of oncology nursing, 2011, Volume: 15, Issue:3

    Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Dacarbazine; Glioblastoma; Humans; Neoplasm Recurrence, Local; Prognosis; Quality of Life; Radiotherapy; Seizures; Temozolomide; United States; Venous Thromboembolism

2011

Other Studies

1 other study(ies) available for dacarbazine and Venous Thromboembolism

ArticleYear
Limited, But Not Eliminated, Excess Long-Term Morbidity in Stage I-IIA Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Limited-Field Radiotherapy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2022, 05-01, Volume: 40, Issue:13

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asthma; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Morbidity; Neoplasm Recurrence, Local; Neoplasm Staging; Venous Thromboembolism; Vinblastine

2022